Other Birds adverse-event record

Other Birds Adverse Event Insights

The FDA Center for Veterinary Medicine database holds 95 adverse event reports for Other Birds, distributed across 2 distinct breeds currently tracked in the system. Of those reports, 56 involved a death outcome, producing a 58.9% case-fatality rate among reported events, which reflects reporting severity bias rather than true population mortality. These figures are aggregated directly from openFDA's Animal & Veterinary Adverse Events endpoint and update as new voluntary submissions flow through pet owners, veterinarians, and drug manufacturers.

The most frequently reported clinical signs for Other Birds are Death (46 reports), Lack of efficacy - NOS (7 reports), Death by euthanasia (6 reports), Lethargy (see also Central nervous system depression in Neurological) (6 reports), with Death leading the reaction traffic at 46 submissions. On the product side, Meloxicam is the single most-referenced drug with 13 reports, followed by Enrofloxacin (12), Isoflurane (10), Polysulfated Glycosaminoglycan (7). This combination surfaces which therapeutic classes generate the most adverse event chatter for this species, a useful starting point when comparing Other Birds reporting patterns against other companion animals in the dataset.

Of the 102 Other Birds reports with a coded outcome, Died accounts for the largest share at 52.0%. Annual submission volume spans 1 to 12 reports across the 16 years on file, a range that reflects evolving owner awareness, veterinary reporting habits, and new product approvals rather than stable underlying incidence. The breed-level table below breaks these patterns down further, showing how the 2 tracked other birds breeds compare on volume, deaths, and average age at report. As with all FDA adverse event data, correlation is the ceiling, causation requires clinical investigation beyond what these aggregates can provide.